Search Within

Michael Scordo

Formats
  1. Meeting Abstract (250)
  2. Journal Article (104)
  3. Research Letter (15)
  4. Correspondence (7)
  5. Editorial (5)
  6. Review (4)
  7. Book Section (1)
  8. Guidelines (1)
Groups
  1. Bone Marrow Transplant (387)
  2. CTCR Scholars (387)
  3. Center for Hematologic Malignancies (387)
  4. Department of Medicine (387)
  5. Hematologic Malignancies, Division of (387)
  6. Survivorship Research (338)

More Groups

People
  1. Gunjan Shah (298)
  2. Sergio Giralt (278)
  3. Miguel-Angel Perales (177)
  4. Sean Devlin (152)
  5. Heather Landau (141)
  6. Parastoo Dahi (140)

More People

Years
  1. 2025 (22)
  2. 2024 (72)
  3. 2023 (81)
  4. 2022 (49)
  5. 2021 (27)
  6. 2020 (53)

More Years

Publications
  1. Blood (123)
  2. Biology of Blood and Marrow Transplantation (56)
  3. Clinical Lymphoma, Myeloma and Leukemia (36)
  4. Bone Marrow Transplantation (26)
  5. Blood Advances (21)
  6. Transplantation and Cellular Therapy (15)

More Publications

Publishers
  1. American Society of Hematology (144)
  2. Elsevier Inc. (122)
  3. Nature Publishing Group (40)
  4. American Society of Clinical Oncology (14)
  5. Wiley Blackwell (9)
  6. Oxford University Press (7)

More Publishers

Results (387)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Radiotherapy for relapse after chimeric antigen receptor T cell therapy in hematologic malignancies
    Meeting Abstract

    Hubbeling, H. G.; Silverman, E. A.; Alarcon Tomas, A.; Tringale, K. R.; Wijetunga, N. A.; Hajj, C.; Mailankody, S.; Batlevi, C. L.; Dahi, P. B.; Giralt, S. A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Evaluation of melphalan exposure in lymphoma patients undergoing BEAM and autologous hematopoietic cell transplantation
    Journal Article

    Dahi, P. B.; Lin, A.; Scordo, M.; Flynn, J. R.; Devlin, S. M.; Ruiz, J. D.; DeRespiris, L.; Carlow, D.; Cho, C.; Lahoud, O. B.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Vitamin D deficiency is associated with inferior clinical outcomes in patients with large B-cell lymphoma receiving anti-CD19 CAR T-cell therapy
    Meeting Abstract

    Nath, K.; Alarcon Tomas, A.; Flynn, J.; Fein, J. A.; Alperovich, A.; Anagnostou, T.; Batlevi, C. W.; Dahi, P. B.; Fingrut, W.; Giralt, S. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Daratumumab salvage therapy for refractory immune cytopenias after ALLOHCT
    Meeting Abstract

    Lin, A.; DeRespiris, L.; Chinapen, S.; Barker, J. N.; Castro-Malaspina, H.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; Lin, R. J.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Interim analysis of the 2nd chance protocol: A multicenter trial of daratumumab, carfilzomib, lenalidomide, & dexamethasone for relapsed/refractory myeloma with salvage autologous hematopoietic cell transplantation
    Meeting Abstract

    Shah, G. L.; Bal, S.; Rodriguez, C.; Chhabra, S.; Bayer, R. L.; Costa, L. J.; Lambird, J.; Ferrer, C.; Parascondola, A.; Marcello, L.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Lesion characteristics and patterns of failure in diffuse large B cell lymphoma patients treated with bridging radiotherapy prior to chimeric antigen receptor T cell therapy
    Meeting Abstract

    Hubbeling, H.; Silverman, E.; Wijetunga, N. A.; Palomba, M. L.; Tomas, A. A.; Shouval, R.; Batlevi, C. W.; Dahi, P. B.; Giralt, S. A.; Lin, R. J.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
    Research Letter

    Stuver, R.; Shah, G. L.; Korde, N. S.; Roeker, L. E.; Mato, A. R.; Batlevi, C. L.; Chung, D. J.; Doddi, S.; Falchi, L.; Gyurkocza, B.; more...
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • Highly favorable outcomes with salvage radiation therapy and autologous hematopoietic cell transplantation in relapsed and refractory DLBCL patients with minimal to no response to salvage chemotherapy
    Research Letter

    Yang, J. C.; Scordo, M.; Chau, K. W.; Sauter, C. S.; Yahalom, J.
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save
  • Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant
    Journal Article

    Miltiadous, O.; Waters, N. R.; Andrlová, H.; Dai, A.; Nguyen, C. L.; Burgos da Silva, M.; Lindner, S.; Slingerland, J.; Giardina, P.; Clurman, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Capture rate of V(D)J sequencing for minimal residual disease detection in multiple myeloma
    Journal Article

    Hultcrantz, M.; Rustad, E. H.; Yellapantula, V.; Jacob, A.; Akhlaghi, T.; Korde, N.; Mailankody, S.; Lesokhin, A. M.; Hassoun, H.; Smith, E. L.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save